BRAF and cancer: Notably, increased levels of HDAC8 in the cytoplasm of patients with metastatic BRAF-mutant melanoma were correlated with better survival, and the HDAC8 localization within tumor cells seems to be important for its biological effects, either positive or negative, on the cancer patient[95].